Megestrolacetaat 160 mg Focus
As listed in the register: Megestrolacetaat 160 mg Focus, tabletten
160 mg · tablet
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Megestrolacetaat
- Made by
- Focus Care Pharmaceuticals B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Spain2 matching products
Canada3 matching products
Details
| Made by | Focus Care Pharmaceuticals B.V. |
|---|---|
| Active substance | Megestrolacetaat |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 160 mg |
| Form | tablet |
| Classification | L02AB01 · Cancer treatments and immune-system medicines |
| Route | oraal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Megestrolacetaat 160 mg Focus, tabletten |
| RVG | 122993 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).